In order to meet the rapidly growing demand of its products in the future, Pegasus Pharmaceuticals Group Inc. has established a Chinese production base for active pharmaceutical ingredients (API) in 2001.  The production baseoccupies 6119 square meters of land with totally 10,150.29 square meters of construction,complying with industrial standards for pharmaceutical production.  It has a capacity for up to 200 million US dollars worth of products per annum.